4-butyrolactone has been researched along with HIV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreca, ML; Chimirri, A; De Luca, L; Debyser, Z; Ferro, S; Monforte, AM; Rao, A; Witvrouw, M | 1 |
| Kappe, T | 1 |
2 other study(ies) available for 4-butyrolactone and HIV
| Article | Year |
|---|---|
New 4-[(1-benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones, beta-diketo acid analogs as HIV-1 integrase inhibitors.
Topics: 4-Butyrolactone; Cell Line; Cell Survival; Drug Design; Enzyme-Linked Immunosorbent Assay; HIV; HIV Integrase Inhibitors; Humans; Indoles; Inhibitory Concentration 50; Keto Acids; Lymphocytes; Microwaves; Models, Molecular; Molecular Structure | 2007 |
Synthesis and in vitro anti-HIV activity of certain 2-(1H-benzimidazol-2-ylamino)pyrimidin-4(3H)-ones and related derivatives.
Topics: 4-Butyrolactone; Anti-HIV Agents; Benzimidazoles; Cell Line; HIV; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Molecular Structure | 1997 |